Literature DB >> 32576385

Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.

Hsu-Liang Chang1, Po-Ju Wei1, Kuan-Li Wu1, Hung-Ling Huang1, Chih-Jen Yang2.   

Abstract

Entities:  

Keywords:  COVID-19; Checkpoint inhibitors; Pneumonitis

Mesh:

Substances:

Year:  2020        PMID: 32576385     DOI: 10.1016/j.lungcan.2020.06.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  5 in total

Review 1.  Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19.

Authors:  M Barnova; A Bobcakova; V Urdova; R Kosturiak; L Kapustova; D Dobrota; M Jesenak
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

2.  Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.

Authors:  Melissa Bersanelli; Diana Giannarelli; Ugo De Giorgi; Sandro Pignata; Massimo Di Maio; Elena Verzoni; Alberto Clemente; Valentina Guadalupi; Diego Signorelli; Marcello Tiseo; Raffaele Giusti; Marco Filetti; Marilena Di Napoli; Lorenzo Calvetti; Alessandro Cappetta; Paola Ermacora; Diego Zara; Fausto Barbieri; Cinzia Baldessari; Vieri Scotti; Francesca Mazzoni; Antonello Veccia; Pamela Francesca Guglielmini; Marco Maruzzo; Ernesto Rossi; Francesco Grossi; Chiara Casadei; Alessio Cortellini; Francesco Verderame; Vincenzo Montesarchio; Mimma Rizzo; Manlio Mencoboni; Fable Zustovich; Lucia Fratino; Saverio Cinieri; Giorgia Negrini; Maria Banzi; Mariella Sorarù; Paolo Andrea Zucali; Gaetano Lacidogna; Antonio Russo; Nicola Battelli; Giuseppe Fornarini; Claudia Mucciarini; Sergio Bracarda; Andrea Bonetti; Debora Pezzuolo; Lucia Longo; Donata Sartori; Mauro Iannopollo; Luigi Cavanna; Fausto Meriggi; Davide Tassinari; Claudia Corbo; Angela Gernone; Veronica Prati; Simona Carnio; Pasqualina Giordano; Angela Maria Dicorato; Claudio Verusio; Francesco Atzori; Francesco Carrozza; Stefania Gori; Antonino Castro; Sara Pilotto; Vanja Vaccaro; Elisabetta Garzoli; Francesco Di Costanzo; Evaristo Maiello; Roberto Labianca; Carmine Pinto; Michele Tognetto; Sebastiano Buti
Journal:  Ther Adv Med Oncol       Date:  2020-11-02       Impact factor: 8.168

Review 3.  Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review.

Authors:  Chih-Jen Yang; Yu-Jui Wei; Hsu-Liang Chang; Pi-Yu Chang; Chung-Chen Tsai; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2020-10-05       Impact factor: 4.399

4.  Immune checkpoint inhibition in COVID-19: risks and benefits.

Authors:  Parmida Sadat Pezeshki; Nima Rezaei
Journal:  Expert Opin Biol Ther       Date:  2021-02-17       Impact factor: 4.388

Review 5.  Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy.

Authors:  Tommaso Morelli; Kohei Fujita; Gil Redelman-Sidi; Paul T Elkington
Journal:  Thorax       Date:  2021-10-04       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.